Global Health Authorities Refute Trump’s Paracetamol–Autism Link Claims
Global Health Authorities Refute Trump’s Paracetamol–Autism Link Claims

Global Health Authorities Refute Trump’s Paracetamol–Autism Link Claims

News summary

US President Donald Trump recently claimed that paracetamol (acetaminophen), commonly sold as Tylenol, causes autism when used during pregnancy, urging pregnant women to avoid it. This assertion has been widely refuted by international health authorities including Singapore's Health Sciences Authority, the Cayman Islands Ministry of Health, and the World Health Organization, all stating there is no conclusive scientific evidence linking paracetamol use during pregnancy to autism. Medical experts emphasize that paracetamol remains the recommended and safest treatment for pain or fever in pregnancy when used appropriately, warning that untreated fever or pain poses real risks to both mother and fetus. Former President Barack Obama criticized Trump's claims as misinformation that could harm public health, increase anxiety among parents, and stigmatize autistic individuals. The US Food and Drug Administration has initiated a label change process for acetaminophen products to mention a "possible association" with autism, a move that has drawn international attention and concern. Industry representatives, such as the chairman of Micro Labs in India, also affirm that robust scientific research does not support a causal link and caution against untreated symptoms during pregnancy.

Story Coverage
Bias Distribution
100% Left
Information Sources
71639883-fbbd-48af-8cc3-393f63e7b2ef166bc319-c612-4063-955b-1bdc4fec97ff
Left 100%
Coverage Details
Total News Sources
2
Left
2
Center
0
Right
0
Unrated
0
Last Updated
19 days ago
Bias Distribution
100% Left
Related News
Ask VT AI
Story Coverage
Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News